Suggestions
Michael Salako PhD MBA
Investment Director at Start Codon
Professional Background
Michael Salako, PhD MBA, is a prominent figure in the life science and deep-tech venture capital investment space. With a wealth of experience in strategic sourcing and technical analysis, Michael has a keen eye for identifying groundbreaking investment opportunities. His expertise extends to structuring, negotiating, and closing complex investment transactions, showcasing his robust skill set as a savvy investor. Additionally, Michael provides invaluable support to portfolio companies, leveraging his deep understanding of the biotech and healthcare landscape.
With an impressive track record, Michael has held significant positions across various organizations. He was a Board Observer at Stealth Mode Biotech, where he played a crucial role in guiding strategic decisions. As a Non-Executive Director at Verinnogen, he contributed to advancing innovative biotechnological solutions. Michael also served as a Board Observer at ArkVax, where he aided in navigating the challenges of the biotech sector. His leadership at Stroma Biosciences and Spliceor further demonstrates his commitment to fostering the growth of pioneering life science enterprises.
Michael began his career as an Investment Director at Start Codon, honing his skills in evaluating early-stage life sciences and healthcare ventures. He was also a Senior Investment Associate at Start Codon on secondment, capitalizing on his strategic insights and fostering relationships with budding entrepreneurs. Through his role as Head of Healthcare Equity Research at Imperial College Business School Investment Fund, Michael provided critical market intelligence and analysis to inform investment strategies. Notably, he also held a pivotal role in Business Development, New Ventures, and Transactions-Commercial Partnerships at Cancer Research UK (CRUK), emphasizing his dedication to advancing cancer research through innovative investment.
Earlier in his career, Michael worked as a Principal Scientist at Cancer Research Technology, where he contributed to essential advancements in drug discovery. His scientific expertise was further enhanced during his time as a Post-Doctoral Fellow at Barts Cancer Institute, specializing in Immuno-Oncology. Drawing on this rich blend of scientific and business acumen, he has become a sought-after speaker, panellist, and judge within the life science and healthcare startup community.
Education and Achievements
Michael has built a solid educational foundation that complements his professional experience. He pursued his Master of Business Administration (MBA) at the prestigious Imperial College London, equipping him with the necessary skills to thrive in the competitive world of venture capital. His academic journey began with a Bachelor of Science (BSc) in Biochemistry at the University of London, where he developed a strong scientific background. Michael further advanced his knowledge by earning his Doctor of Philosophy (PhD) in Molecular Virology and Molecular Toxicology at the University of Surrey, deepening his understanding of key scientific concepts essential for his future endeavors.
In addition to his formal education, Michael is a Certified Licensing Professional, which substantiates his expertise in intellectual property and licensing within the life sciences sector. His numerous awards and scholarships highlight his exceptional commitment to advancing his field and his dedication to lifelong learning. Michael remains engaged with the academic community and frequently shares his insights as a guest speaker or judge at various life science and healthcare events.
Achievements
Throughout his career, Michael has received various accolades that underscore his contributions to the life sciences and venture capital sectors. His technical expertise, combined with a business-centric approach, has allowed him to forge meaningful collaborations and drive successful investment strategies. His role in shaping the future of healthcare through venture capital highlights his commitment and passion for supporting innovative solutions in the life sciences.
Michael's engagement as a panellist and judge at various startup competitions speaks to his reputation as an authority in the industry. By sharing his insights and perspectives, he educates and inspires the next generation of entrepreneurs in the biotech space. Michael's unique blend of scientific knowledge and business acumen positions him as a leader who significantly impacts the life science sector and its future direction.
